Skip to main content
OpenTrials

Clinical trial condition

Fibrolamellar Liver Cancer

Explore clinical trials studying Fibrolamellar Liver Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Fibrolamellar Liver Cancer trial results

Completed

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

NCT01642186

Conditions
Fibrolamellar Carcinoma, Fibrolamellar Liver Cancer, Fibrolamellar hepatocellular carcinoma
Locations
  • University of California San Francisco San Francisco, California, United States
  • John Hopkins Medical Center Baltimore, Maryland, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions